TGFB1 and neoplasm: Increased PD-L1 expression by metastatic and dormant cells, as well as the immune-modulatory effects exerted by Tregs and MDSCs through the secretion of TGF-β1 and IL-10, play a role in compromising the anti-tumor activity of NK and adaptive T cells.